Form 4: 180 Life Sciences Director Stephen Shoemaker Acquires 65,000 Shares of Common Stock

Director Stephen Shoemaker acquired 65,000 shares of 180 Life Sciences Corp. common stock on February 20, 2025, as compensation for services.

Summary

• On February 20, 2025, Stephen H. Shoemaker, a director of 180 Life Sciences Corp., acquired 65,000 shares of common stock.
• The acquisition was made as compensation for services rendered and to be rendered as a member of the Board of Directors.
• The shares were issued under the Issuer's 2022 Equity Compensation Plan.
• The restricted stock shares are subject to time-based vesting, with 1/2 vesting on July 1, 2025, and the remaining 1/2 on December 31, 2025, contingent upon continued service to the Issuer.
• The price per share was $0.0.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director's acquisition of shares indicates confidence in the company, and the vesting schedule promotes long-term commitment. There are no immediate negative implications.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The vesting schedule incentivizes continued service and commitment from the director.

Future Outlook

The vesting schedule suggests an expectation of continued service from the director through the end of 2025.

Industry Context

This type of equity compensation is common for directors of publicly traded companies, aligning their interests with those of shareholders.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates

Keywords

180 Life Sciences Corp., Stephen Shoemaker, Director, Stock Acquisition, Form 4, Equity Compensation, Vesting